D-1084-2019 Class III Terminated

Recalled by X-Gen Pharmaceuticals Inc. — Horseheads, NY

FDA drug recall D-1084-2019 was initiated by X-Gen Pharmaceuticals Inc. on Mar 29, 2019 and is designated Class III. Reason for recall: Labeling: Label Error on Declared Strength: Side carton panel incorrectly lists the concentration as "500 mcg Clonidine Hydrochloride" rather than the correct concentration of "100 mcg Clonidine… The recall status is terminated (terminated Jun 2, 2021). Affected quantity: 24,966 vials.

Recall details

Product Type
Drugs
Report Date
Apr 17, 2019
Initiation Date
Mar 29, 2019
Termination Date
Jun 2, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
24,966 vials

Product description

Clonidine HCL Injection, 1000 mcg/10mL (100 mcg/mL), 10 ML Single Dose Vial, Rx only, Manufactured for: X-Gen Pharmaceuticals, Big Flats, NY 14814, NDC 39822-2000-1.

Reason for recall

Labeling: Label Error on Declared Strength: Side carton panel incorrectly lists the concentration as "500 mcg Clonidine Hydrochloride" rather than the correct concentration of "100 mcg Clonidine Hydrochloride" per mL.

Distribution pattern

Nationwide in the USA.

Code information

Lots #: PMXA1917, Exp 09/2020; PMXA1937, PMXA1938, Exp 11/2020;

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1084-2019
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1084-2019. Report a data issue: hello@regdatalab.com.